The IGC of the Calouste Gulbenkian Foundation will create the first single cell analysis CVTT in Portugal (Single Cell Hub), a non-existing differentiating service that brings together cutting-edge technology and scientific excellence, in an emerging and critical area for biomedicine. This infrastructure will allow the creation of a collaborative network that strengthens the scientific and business structure, generating new approaches that benefit public health.